Evidence map›Paper›PMID 34310888›Full record

ArticleInfection and immunity2021

An

Matthew K Muramatsu, Jianli Zhou, Bryna L Fitzgerald, Ranjit K Deka, John T Belisle, Michael V Norgard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew K MuramatsuDepartment of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.
Jianli ZhouDepartment of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.
Bryna L FitzgeraldDepartment of Microbiology, Immunology, and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Ranjit K DekaDepartment of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.
John T BelisleDepartment of Microbiology, Immunology, and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Michael V NorgardDepartment of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-0407-9911

Funding

The flavin-centric metabolic lifestyle of Treponema pallidumR01AI056305 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI HENDRIXSON, DAVID R · 2003 to 2024
$9.6M
The RpoN-RpoS regulatory pathway in Borrelia burgdorferiR01AI059062 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI NORGARD, MICHAEL V. · 2004 to 2019
$6.2M
The RpoN-RpoS regulatory pathway in Borrelia burgdorferiR56AI059062 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI NORGARD, MICHAEL V. · 2009 to 2009
$323k
NIAID NIH HHS R01 AI056305NIAID NIH HHS R01 AI059062NIAID NIH HHS R56 AI059062
6 · The paper itself

Abstract

Riboflavin is an essential micronutrient, but its transport and utilization have remained largely understudied among pathogenic spirochetes. Here, we show that Borrelia burgdorferi, the zoonotic spirochete that causes Lyme disease, is able to import riboflavin via products of its

Indexed as

AnimalsBacterial ProteinsBorrelia burgdorferiFemaleLyme DiseaseMammalsMiceMice, Inbred C3HOperonRiboflavinBacterial ProteinsRiboflavinBorrelia burgdorferiLyme diseaseRfuABCDriboflavinroseoflavin

Identifiers

PMID34310888
PMCPMC8445183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.